Cornerstone Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Cornerstone Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$254K	Buy	+335	New	+$253K	0.01%	649
2026 Q2	–	Sell	-300	Closed	-$232K	–	775
2026 Q1	$232K	Sell	300 -10	-3%	-$7.66K	0.01%	641
2025 Q4	$239K	Buy	+310	New	+$211K	0.01%	611
2025 Q1	–	Sell	-310	Closed	-$221K	–	614
2024 Q4	$221K	Buy	310 +10	+3%	+$8.39K	0.01%	539
2024 Q3	$315K	Sell	300 -17	-5%	-$18.9K	0.02%	449
2024 Q2	$333K	Buy	317 +17	+6%	+$16.5K	0.03%	416
2024 Q1	$289K	Hold	300	–	–	0.02%	433
2023 Q4	$263K	Sell	300 -3	-1%	-$2.47K	0.02%	436
2023 Q3	$249K	Buy	303 +3	+1%	+$2.36K	0.02%	456
2023 Q2	$216K	Sell	300 -90	-23%	-$69.4K	0.02%	474
2023 Q1	$320K	Buy	+390	New	+$294K	0.03%	363
2022 Q3	$322K	Hold	468	–	–	0.04%	334
2022 Q2	$277K	Buy	468 +78	+20%	+$50.7K	0.03%	365
2022 Q1	$272K	Sell	390 -14	-3%	-$8.86K	0.03%	383
2021 Q4	$254K	Buy	+404	New	+$248K	0.02%	435

Other funds holding REGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Cornerstone Wealth Management's REGN Position: Q3 2026 in Review

Cornerstone Wealth Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 335 shares worth $254K. The stake represents 0.01% of the portfolio and ranks #649 among its holdings. This is a return to the name: Cornerstone Wealth Management previously reported a position in REGN as recently as Q1 2026.

Cornerstone Wealth Management first reported a position in REGN in Q4 2021 and has held it in 15 quarters since. The position peaked at $333K in Q2 2024. 806 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

Cornerstone Wealth Management held 335 shares of Regeneron Pharmaceuticals worth $254K as of Q3 2026.
Regeneron Pharmaceuticals was a new Cornerstone Wealth Management position in Q3 2026.
Regeneron Pharmaceuticals made up 0.01% of Cornerstone Wealth Management's portfolio in Q3 2026, its #649 holding.
Cornerstone Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 15 quarters since.
Cornerstone Wealth Management's Regeneron Pharmaceuticals position peaked at $333K in Q2 2024.
806 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Cornerstone Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.